Overview

Efficacy and Safety of Brimonidine Tartrate Ophthalmic Solution in Adult and Geriatric Participants With Ocular Redness

Status:
Completed
Trial end date:
2013-12-20
Target enrollment:
Participant gender:
Summary
To compare the efficacy and safety of brimonidine tartrate ophthalmic solution 0.025% with its vehicle for the treatment of ocular redness in a population of adult and geriatric participants with ocular redness.
Phase:
Phase 3
Details
Lead Sponsor:
Bausch & Lomb Incorporated
Collaborator:
ORA, Inc.
Treatments:
Brimonidine Tartrate
Ophthalmic Solutions
Pharmaceutical Solutions